Brief: Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
11/06/2026 02:28
BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review June 11 (Reuters) - Imricor Medical Systems, Inc IMR.AX:
SUBMISSION OF THE THIRD PMA MODULE TO THE US FDA FOR REVIEW
SUBMISSION INCLUDES VISION-MR ABLATION CATHETER 2, RF-5000 GENERATOR, RF-5000 TUBING SET
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion